A team in Pittsburgh received a $2.3 million grant to fast-track the development and clinical transition of a minimally ...

The global hydrocephalus shunt market is poised for steady expansion, with Future Market Insights (FMI) projecting a market ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

One month after Merrick was born, his mom, Lindsey, felt that something wasn’t quite right with her baby boy. He’d become ...

Wireless brain sensor aims to prevent failures, giving hydrocephalus patients early alerts before symptoms become critical.

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

Current risk/benefit analyses indicate that shunt operations improve outcome compared to the spontaneous course of the disease. Conclusion: Normal pressure hydrocephalus should always enter into ...

I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter ...